Related references
Note: Only part of the references are listed.No Evidence of Hepatitis C Virus (HCV)-Assisted Hepatitis D Virus Propagation in a Large Cohort of HCV-Positive Blood Donors
Pierre Cappy et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Hepatitis delta virus propagation enabled by hepatitis C virus-Scientifically intriguing, but is it relevant to clinical practice?
Lisa Sophie Pflueger et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Analysis of Host Responses to Hepatitis B and Delta Viral Infections in a Micro-scalable Hepatic Co-culture System
Benjamin Y. Winer et al.
HEPATOLOGY (2020)
Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
Zhijiang Miao et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection
Xiaoming Cheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis
Alexander J. Stockdale et al.
JOURNAL OF HEPATOLOGY (2020)
Current knowledge on Hepatitis Delta Virus replication
Julie Lucifora et al.
ANTIVIRAL RESEARCH (2020)
Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro
Richard Boulon et al.
ANTIVIRAL RESEARCH (2020)
Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta
Anika Wranke et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Mammalian deltavirus without hepadnavirus coinfection in the neotropical rodent Proechimys semispinosus
Sofia . Paraskevopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Phase 2 Study of Peginterferon Lambda, Lonafarnib and Ritonavir for 24 Weeks: End-of-Treatment Results from the LIFT HDV Study
Christopher Koh et al.
JOURNAL OF HEPATOLOGY (2020)
48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection
Heiner Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2020)
TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
Carla Usai et al.
JHEP REPORTS (2020)
RIG-I-like receptors: their regulation and roles in RNA sensing
Jan Rehwinkel et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
Katja Giersch et al.
GUT (2019)
Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
Hai-Yan Chen et al.
GUT (2019)
Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status
Johanna Landahl et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level
Hadi Karimzadeh et al.
GASTROENTEROLOGY (2019)
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer et al.
LANCET INFECTIOUS DISEASES (2019)
Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells
Matthieu Blanchet et al.
ANTIVIRAL RESEARCH (2019)
Plasmacytoid Dendritic Cells and Infected Cells Form an Interferogenic Synapse Required for Antiviral Responses
Sonia Assil et al.
CELL HOST & MICROBE (2019)
SAT-202-Endogenous and exogenous IFN responses suppress HDV persistence during proliferation of hepatocytes in vitro
Zhenfeng Zhang et al.
JOURNAL OF HEPATOLOGY (2019)
End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection
Ohad Etzion et al.
JOURNAL OF HEPATOLOGY (2019)
Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection
Heiner Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2019)
Identification of a Novel Deltavirus in Boa Constrictors
Udo Hetzel et al.
MBIO (2019)
Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
Jimena Perez-Vargas et al.
NATURE COMMUNICATIONS (2019)
Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation
Florian A. Lempp et al.
NATURE COMMUNICATIONS (2019)
Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus
Yi Ni et al.
SCIENTIFIC REPORTS (2019)
Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat
Shafaqat Ali et al.
FRONTIERS IN IMMUNOLOGY (2019)
REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV Infection
Andrew Vaillant
ACS INFECTIOUS DISEASES (2019)
Pathogenesis of and New Therapies for Hepatitis D
Christopher Koh et al.
GASTROENTEROLOGY (2019)
Hepatitis D Virus-Specific CD8D+ T Cells Have a Memory-Like Phenotype Associated With Viral Immune Escape in Patients With Chronic Hepatitis D Virus Infection
Helenie Kefalakes et al.
GASTROENTEROLOGY (2019)
Stimulation of Innate Immunity by Host and Viral RNAs
Felix Streicher et al.
TRENDS IN IMMUNOLOGY (2019)
Automated nucleic acid isolation methods for HDV viral load quantification can lead to viral load underestimation
Birgit Bremer et al.
ANTIVIRAL THERAPY (2019)
Novel hepatitis D-like agents in vertebrates and invertebrates
Wei-Shan Chang et al.
VIRUS EVOLUTION (2019)
Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection In Vitro
Frauke Beilstein et al.
JOURNAL OF VIROLOGY (2018)
Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver
Aleksei Suslov et al.
GASTROENTEROLOGY (2018)
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
Pascal Mutz et al.
GASTROENTEROLOGY (2018)
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study
Cihan Yurdaydin et al.
HEPATOLOGY (2018)
Subanalysis of the LOWR HDV-2 study reveals high response rates to Lonafarnib in patients with low viral loads
C. Yurdaydin et al.
JOURNAL OF HEPATOLOGY (2018)
Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
H. Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2018)
Hepatitis D virus replication is sensed by MDA5 and induces IFN-beta/lambda responses in hepatocytes
Zhenfeng Zhang et al.
JOURNAL OF HEPATOLOGY (2018)
Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
Cihan Yurdaydin et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an In Vitro Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles
Thomas Tu et al.
JOURNAL OF VIROLOGY (2018)
Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8(+) T Cells
Hadi Karimzadeh et al.
JOURNAL OF VIROLOGY (2018)
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection
Benjamin Y. Winer et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
Thomas Tu et al.
CURRENT OPINION IN VIROLOGY (2018)
Nuclear-resident RIG-I senses viral replication inducing antiviral immunity
GuanQun Liu et al.
NATURE COMMUNICATIONS (2018)
A Divergent Hepatitis D-Like Agent in Birds
Michelle Wille et al.
VIRUSES-BASEL (2018)
Antiviral Treatment and Liver- Related Complications in Hepatitis Delta
Anika Wranke et al.
HEPATOLOGY (2017)
The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells
Thomas Schirdewahn et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Extracellular Vesicles Deliver Host and Virus RNA and Regulate Innate Immune Response
Takahisa Kouwaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Sequencing of the Hepatitis D Virus RNA WHO International Standard
M. T. Pyne et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis - end of study results from the LOWR HDV-3 study
C. Koh et al.
JOURNAL OF HEPATOLOGY (2017)
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction
Lester Suarez-Amaran et al.
JOURNAL OF HEPATOLOGY (2017)
A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
H. Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2017)
Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm
Aakanksha Jain et al.
JOURNAL OF IMMUNOLOGY (2017)
Expression of Ifnlr1 on Intestinal Epithelial Cells Is Critical to the Antiviral Effects of Interferon Lambda against Norovirus and Reovirus
Megan T. Baldridge et al.
JOURNAL OF VIROLOGY (2017)
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Hepatitis delta: virological and clinical aspects
Luan Felipo Botelho-Souza et al.
VIROLOGY JOURNAL (2017)
Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen
Florian A. Lempp et al.
VIRUSES-BASEL (2017)
Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes
Clement Guillot et al.
PLOS ONE (2017)
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
Katja Giersch et al.
SCIENTIFIC REPORTS (2017)
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
Michel Bazinet et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses
Eloi R. Verrier et al.
HEPATOLOGY (2016)
HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes
Dulce Alfaiate et al.
ANTIVIRAL RESEARCH (2016)
First international external quality assessment for hepatitis delta virus RNA quantification in plasma
Frederic Le Gal et al.
HEPATOLOGY (2016)
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
Henry L. Y. Chan et al.
JOURNAL OF HEPATOLOGY (2016)
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
Pavel Bogomolov et al.
JOURNAL OF HEPATOLOGY (2016)
The hepatitis delta virus: Replication and pathogenesis
Camille Sureau et al.
JOURNAL OF HEPATOLOGY (2016)
Cell-Cell Sensing of Viral Infection by Plasmacytoid Dendritic Cells
Brian Webster et al.
JOURNAL OF VIROLOGY (2016)
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
Florian A. Lempp et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Viral evasion of intracellular DNA and RNA sensing
Ying Kai Chan et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg plus Chronic Hepatitis B Infection
Mamun Al-Mahtab et al.
PLOS ONE (2016)
Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection
Katja Giersch et al.
JOURNAL OF HEPATOLOGY (2015)
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
Christopher Koh et al.
LANCET INFECTIOUS DISEASES (2015)
Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide
Wenhui He et al.
PLOS PATHOGENS (2015)
Crosstalk between innate and adaptive immunity in hepatitis B virus infection
Li Wang et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte
Katja Giersch et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2015)
Long-term therapy of chronic delta hepatitis with peginterferon alfa
T. Heller et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
Benjamin Heidrich et al.
HEPATOLOGY (2014)
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J. Muir et al.
JOURNAL OF HEPATOLOGY (2014)
Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection
Katja Giersch et al.
JOURNAL OF HEPATOLOGY (2014)
Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles
Natalia Freitas et al.
JOURNAL OF VIROLOGY (2014)
Hepatitis Delta Antigen Requires a Flexible Quasi-Double-Stranded RNA Structure To Bind and Condense Hepatitis Delta Virus RNA in a Ribonucleoprotein Complex
Brittany L. Griffin et al.
JOURNAL OF VIROLOGY (2014)
Incoming RNA Virus Nucleocapsids Containing a 5′-Triphosphorylated Genome Activate RIG-I and Antiviral Signaling
Michaela Weber et al.
CELL HOST & MICROBE (2013)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Tassilo Volz et al.
JOURNAL OF HEPATOLOGY (2013)
Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors
Oscar Lamas Longarela et al.
PLOS ONE (2013)
Meta-analysis: antiviral treatment for hepatitis D
C. Triantos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Short-Range Exosomal Transfer of Viral RNA from Infected Cells to Plasmacytoid Dendritic Cells Triggers Innate Immunity
Marlene Dreux et al.
CELL HOST & MICROBE (2012)
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation
Marc Luetgehetmann et al.
HEPATOLOGY (2012)
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation
Ingmar Mederacke et al.
JOURNAL OF HEPATOLOGY (2012)
Clinical Features of Hepatitis D
Patrizia Farci et al.
SEMINARS IN LIVER DISEASE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
Heiner Wedemeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interferon Impedes an Early Step of Hepatitis Delta Virus Infection
Ziying Han et al.
PLOS ONE (2011)
Targeting protein prenylation for cancer therapy
Norbert Berndt et al.
NATURE REVIEWS CANCER (2011)
Outcome of chronic delta hepatitis in Italy: A long-term cohort study
Grazia Anna Niro et al.
JOURNAL OF HEPATOLOGY (2010)
Natural history and treatment of chronic delta hepatitis
C. Yurdaydin et al.
JOURNAL OF VIRAL HEPATITIS (2010)
A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
Raffaella Romeo et al.
GASTROENTEROLOGY (2009)
Hepatitis Delta Virus Inhibits Alpha Interferon Signaling
Paolo Pugnale et al.
HEPATOLOGY (2009)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Transcription of hepatitis delta virus RNA by RNA polymerase II
Jinhong Chang et al.
JOURNAL OF VIROLOGY (2008)
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans
Andreas Schulze et al.
HEPATOLOGY (2007)
Assembly of hepatitis delta virus: Particle characterization, including the ability to infect primary human hepatocytes
Severin Gudima et al.
JOURNAL OF VIROLOGY (2007)
The human RNA polymerase II interacts with the terminal stem-loop regions of the hepatitis delta virus RNA genome
Valerie S. Greco-Stewart et al.
VIROLOGY (2007)
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes
Sean E. Doyle et al.
HEPATOLOGY (2006)
Efficacy of peginterferon alpha-2b in chronic hepatitis delta:: Relevance of quantitative RT-PCR for follow-up
Corinne Castelnau et al.
HEPATOLOGY (2006)
Cytotoxic CD4+ T cells in viral hepatitis
N. Aslan et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Biological activity of interleukins-28 and-29: Comparison with type I interferons
A Meager et al.
CYTOKINE (2005)
Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes
D Glebe et al.
GASTROENTEROLOGY (2005)
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein
P Gripon et al.
JOURNAL OF VIROLOGY (2005)
Genomic analysis of the host response to hepatitis B virus infection
S Wieland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Long-term benefit of interferon a therapy of chronic hepatitis D: Regression of advanced hepatic fibrosis
P Farci et al.
GASTROENTEROLOGY (2004)
Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action
J Chang et al.
JOURNAL OF VIROLOGY (2003)
Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases
TB Macnaughton et al.
JOURNAL OF VIROLOGY (2002)
Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA
S Gudima et al.
JOURNAL OF VIROLOGY (2002)
Advances in immunology: Innate immunity.
R Medzhitov et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
G Fattovich et al.
GUT (2000)
Share Paper
